您好,欢迎来到佐思信息
全国服务热线:
400-009-0050
佐思信息专注支持企业决策
您当前的位置:首页>>研究报告>>其他医疗设备

2016-2021年血液采集市场研究报告
Blood Collection Market by Product (Syringes, Needles, EDTA, Heparin, Serum, Tubes, Blood Lancets, Blood Bags, Vials), Application (Diagnostic, Treatment, Infectious Diseases, Non Infectious Diseases) & End User (Blood Banks, Hospitals) - Forecast to 2021

2016-2021年血液采集市场研究报告
【报告编号】:No.25865
【发布时间】:2016-07
【关 键 字】:blood collection     血液采集        
【报告页数】:157页
【报告价格】:电子版:5650美元
【交付方式】:Email发送或EMS快递
【订购热线】:


400-009-0050(全国24小时服务)
北京:010-82863481
上海:021-64871266 021-64872612

报告目录下载订购协议下载在线咨询

    专业、专注于为企业提供真正有价值的全球市场调查信息,是我们的使命。我们是中国第一家汇集全球众多行业研究机构研究成果的平台,致力于为企业决策提供最有效的市场资讯,特别是为中国企业了解和进入国际市场迈出第一步,提供全面的信息参考,我们跨越语言及时间的障碍,在信息爆炸的当下,努力为客户提供最有价值的全球产业资讯。我们公司也拥有独立的研究机构,聚焦于中国市场的研究,为国内外企业在中国市场大展宏图提供市场研究支持。

• 我们在全球的合作伙伴>>• 我们的研究中心>>

  • 英文摘要
  • 中文摘要
  • 索取简版报告
  • 其他医疗设备行业的相关报告
Report Description
 
The blood collection market is expected reach USD 9.90 billion by 2021 from USD 7.65 billion in 2016, at CAGR of 5.3% from 2016 to 2021. Factors such as increasing number of surgical procedures requiring blood transfusions, rising prevalence of diseases, and growing number of accidental and trauma cases are driving growth in the blood collection market. However, risks associated with blood transfusions in underdeveloped regions is expected to restrain the growth of the blood collection market to a certain extent.
 
In this report, the blood collection market is segmented on the basis of products, applications, end users, and regions. On the basis of products, the blood collection market is categorized into blood collection needles and syringes, blood collection tubes, blood lancets, blood bags, vials, and others (microscopic slides, slide stainers, and test tube racks). The blood collection needles and syringes segment is expected to account for the largest share of the blood collection market in 2016. The increasing demand of blood collection needles and syringes in blood collection procedures (due to the increasing number of surgeries) is the major factor contributing to the growth of this segment.
 
The blood collection market, by application, is segmented into diagnostics and treatment applications. The diagnostics segment is further divided into infectious diseases and non-infectious diseases. The diagnostics segment is expected to account for the largest share of the blood collection market in 2016. The increasing demand for blood in diagnostic procedures and increasing number of accidental and trauma cases are the major factors driving the growth of the diagnostics market. 
 
On the basis of end users, the blood collection market is segmented into hospitals and diagnostic centers, blood banks, and other end users (long-term acute care centers, trauma centers, and nursing homes). The hospitals and diagnostic centers segment is expected to account for the largest share of the blood collection market in 2016. The large share of this segment is primarily attributed to the increasing demand of donated blood, growing number of organ transplantation surgeries, and increasing number of blood donations worldwide.
 
North America is expected to account for the largest share of the blood collection market in 2016. The implementation of favorable government initiatives for blood safety is the major factor driving the growth of the blood collection market in North America. The Asia-Pacific market, on the other hand, is expected to grow at the highest CAGR in the forecast period. This market is primarily driven by the increasing incidences of infectious diseases.
 
 
The key players in the blood collection market are Becton, Dickinson and Company (U.S.), Abbott Laboratories (U.S.), Nipro Medical Corporation (Japan), and Terumo Corporation (Japan).
 
Reasons to buy this report:
From an insight perspective, this research report has focused on various levels of analyses—industry analysis (industry trends), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the blood collection market, high-growth regions, and market drivers, restraints, and opportunities.
 
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on products offered by the top players in the global blood collection market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the blood collection market
• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for blood collection across regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global blood collection market 
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global blood collection market
 
Table of Contents
 
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
 
2 RESEARCH METHODOLOGY 18
2.1 MARKET SIZE ESTIMATION 19
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.2.1 KEY DATA FROM SECONDARY SOURCES 23
2.2.2 KEY DATA FROM PRIMARY SOURCES 23
2.2.2.1 Key industry insights 24
2.2.3 ASSUMPTIONS FOR THE STUDY 24
 
3 EXECUTIVE SUMMARY 25
3.1 INTRODUCTION 25
3.2 CURRENT SCENARIO 25
3.3 FUTURE OUTLOOK 26
3.4 CONCLUSION 29
 
4 PREMIUM INSIGHTS 30
4.1 BLOOD COLLECTION: MARKET OVERVIEW 30
4.2 GEOGRAPHIC ANALYSIS: BLOOD COLLECTION MARKET, BY PRODUCT 31
4.3 BLOOD COLLECTION MARKET, BY DIAGNOSTIC APPLICATION 32
4.4 BLOOD COLLECTION MARKET, BY END USER 32
4.5 BLOOD COLLECTION MARKET, BY APPLICATION 33
4.6 GEOGRAPHICAL SNAPSHOT OF THE BLOOD COLLECTION MARKET 33
4.7 LIFECYCLE ANALYSIS, BY REGION 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.3 MARKET DYNAMICS 37
5.3.1 DRIVERS 37
5.3.1.1 Rising incidences of diseases 37
5.3.1.2 Growing number of accident and trauma cases 38
5.3.1.3 Increasing number of surgeries 39
5.3.2 RESTRAINTS 39
5.3.2.1 Risks associated with blood transfusions in underdeveloped regions 39
5.3.3 OPPORTUNITIES 40
5.3.3.1 Use of RFID in the transfusion process 40
5.3.3.2 Needle-free devices 40
5.3.4 CHALLENGES 41
5.3.4.1 Regulatory challenges 41
 
6 BLOOD COLLECTION MARKET, BY PRODUCT 42
6.1 INTRODUCTION 43
6.2 BLOOD COLLECTION NEEDLES AND SYRINGES 44
6.3 BLOOD COLLECTION TUBES 46
6.3.1 EDTA TUBES 49
6.3.2 HEPARIN TUBES 50
6.3.3 SERUM SEPARATING TUBES 51
6.3.4 PLASMA SEPARATING TUBES 52
6.4 BLOOD LANCETS 53
6.5 BLOOD BAGS 55
6.6 VIALS 57
6.7 OTHER BLOOD COLLECTION PRODUCTS 59
 
7 BLOOD COLLECTION MARKET, BY APPLICATION 61
7.1 INTRODUCTION 62
7.2 DIAGNOSTIC APPLICATIONS 63
7.2.1 INFECTIOUS DISEASES 65
7.2.2 NON-INFECTIOUS DISEASES 68
7.3 TREATMENT 70
8 BLOOD COLLECTION MARKET, BY END USER 72
8.1 INTRODUCTION 73
8.1.1 HOSPITALS AND DIAGNOSTIC CENTERS 74
8.1.2 BLOOD BANKS 76
8.1.3 OTHER END USERS 78
 
9 BLOOD COLLECTION MARKET, BY REGION 80
9.1 INTRODUCTION 81
9.2 NORTH AMERICA 83
9.2.1 U.S. 88
9.2.2 CANADA 90
9.3 EUROPE 93
9.3.1 GERMANY 96
9.3.2 U.K. 98
9.3.3 FRANCE 101
9.3.4 ROE 103
9.4 ASIA-PACIFIC (APAC) 106
9.5 REST OF THE WORLD (ROW) 111
 
10 COMPETITIVE LANDSCAPE 114
10.1 OVERVIEW 115
10.2 BATTLE FOR MARKET SHARE 116
10.3 PRODUCT LAUNCHES 117
10.4 ACQUISITIONS 118
10.5 EXPANSIONS 119
10.6 AGREEMENTS AND PARTNERSHIPS 120
10.7 OTHER DEVELOPMENTS 121
 
11 COMPANY PROFILES 122
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION 122
11.2 ABBOTT LABORATORIES INC. 123
11.3 MEDTRONIC 125
11.4 BECTON, DICKINSON AND COMPANY 128
11.5 TERUMO CORPORATION 131
11.6 NIPRO MEDICAL CORPORATION 133
11.7 QIAGEN 136
11.8 F.L. MEDICAL SRL 138
11.9 GREINER HOLDING AG 140
11.10 HAEMONETICS CORPORATION 143
11.11 SARSTEDT AG & CO. 145
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
 
12 APPENDIX 146
12.1 INSIGHTS OF INDUSTRY EXPERTS 146
12.2 DISCUSSION GUIDE 147
12.3 OTHER DEVELOPMENTS 150
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 152
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 154
12.6 AVAILABLE CUSTOMIZATIONS 155
12.7 RELATED REPORTS 156
 
List Of Tables
TABLE 1 GLOBAL PREVALENCE OF DISEASES 38
TABLE 2 DEATH RATE (PER 100,000 PEOPLE) DUE TO ROAD ACCIDENTS IN 2014 38
TABLE 3 PREVALENCE OF TRANSFUSION TRANSMISSIBLE INFECTIONS IN BLOOD DONATIONS, BY INCOME GROUP (2012) 39
TABLE 4 INDICATIVE LIST OF COMPANIES THAT RECEIVED FDA APPROVALS FOR NEEDLE-FREE DEVICES 40
TABLE 5 BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 43
TABLE 6 BLOOD COLLECTION MARKET SIZE FOR NEEDLES AND SYRINGES, BY REGION, 2014–2021 (USD MILLION) 45
TABLE 7 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR NEEDLES AND SYRINGES, BY COUNTRY, 2014–2021 (USD MILLION) 45
TABLE 8 EUROPE: BLOOD COLLECTION MARKET SIZE FOR NEEDLES AND SYRINGES, 
BY COUNTRY, 2014–2021 (USD MILLION) 45
TABLE 9 BLOOD COLLECTION MARKET SIZE FOR TUBES, BY TYPE, 
2014–2021 (USD MILLION) 47
TABLE 10 BLOOD COLLECTION MARKET SIZE FOR TUBES, BY REGION, 
2014–2021 (USD MILLION) 47
TABLE 11 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR TUBES, 
BY REGION, 2014–2021 (USD MILLION) 47
TABLE 12 EUROPE: BLOOD COLLECTION MARKET SIZE FOR TUBES, BY REGION, 
2014–2021 (USD MILLION) 48
TABLE 13 BLOOD COLLECTION MARKET SIZE FOR EDTA TUBES, BY REGION, 
2014–2021 (USD MILLION) 49
TABLE 14 BLOOD COLLECTION MARKET SIZE FOR HEPARIN TUBES, BY REGION, 
2014–2021 (USD MILLION) 50
TABLE 15 BLOOD COLLECTION MARKET SIZE FOR SERUM SEPARATING TUBES, 
BY REGION, 2014–2021 (USD MILLION) 51
TABLE 16 BLOOD COLLECTION MARKET SIZE FOR PLASMA SEPARATING TUBES, 
BY REGION, 2014–2021 (USD MILLION) 52
TABLE 17 BLOOD COLLECTION MARKET SIZE FOR BLOOD LANCETS, BY REGION, 
2014–2021 (USD MILLION) 54
TABLE 18 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR BLOOD LANCETS, 
BY COUNTRY, 2014–2021 (USD MILLION) 54
TABLE 19 EUROPE: BLOOD COLLECTION MARKET SIZE FOR BLOOD LANCETS, 
BY COUNTRY, 2014–2021 (USD MILLION) 54
TABLE 20 BLOOD COLLECTION MARKET SIZE FOR BLOOD BAGS, BY REGION, 
2014–2021 (USD MILLION) 56
TABLE 21 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR BLOOD BAGS, 
BY COUNTRY, 2014–2021 (USD MILLION) 56
TABLE 22 EUROPE: BLOOD COLLECTION MARKET SIZE FOR BLOOD BAGS, 
BY COUNTRY, 2014–2021 (USD MILLION) 56
TABLE 23 BLOOD COLLECTION MARKET SIZE FOR VIALS, BY REGION, 
2014–2021 (USD MILLION) 57
TABLE 24 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR VIALS, 
BY REGION, 2014–2021 (USD MILLION) 58
TABLE 25 EUROPE: BLOOD COLLECTION MARKET SIZE FOR VIALS, BY COUNTRY, 
2014–2021 (USD MILLION) 58
TABLE 26 BLOOD COLLECTION MARKET SIZE FOR OTHER BLOOD COLLECTION PRODUCTS, BY REGION, 2014–2021 (USD MILLION) 59
TABLE 27 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR OTHER BLOOD COLLECTION PRODUCTS, BY REGION, 2014–2021 (USD MILLION) 60
TABLE 28 EUROPE: BLOOD COLLECTION MARKET SIZE FOR OTHER BLOOD COLLECTION PRODUCTS, BY COUNTRY, 2014–2021 (USD MILLION) 60
TABLE 29 BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 62
TABLE 30 BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, 
BY TYPE, 2014–2021 (USD MILLION) 64
TABLE 31 BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, 
BY REGION, 2014–2021 (USD MILLION) 64
TABLE 32 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 64
TABLE 33 EUROPE: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, 
BY COUNTRY, 2014–2021 (USD MILLION) 65
TABLE 34 BLOOD COLLECTION MARKET SIZE FOR INFECTIOUS DISEASES, 
BY REGION, 2014–2021 (USD MILLION) 66
TABLE 35 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2014–2021 (USD MILLION) 67
TABLE 36 EUROPE: BLOOD COLLECTION MARKET SIZE FOR INFECTIOUS DISEASES, 
BY COUNTRY, 2014–2021 (USD MILLION) 67
TABLE 37 BLOOD COLLECTION MARKET SIZE FOR NON-INFECTIOUS DISEASES, 
BY REGION, 2014–2021 (USD MILLION) 68
TABLE 38 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR NON-INFECTIOUS DISEASES, BY COUNTRY, 2014–2021 (USD MILLION) 69
TABLE 39 EUROPE: BLOOD COLLECTION MARKET SIZE FOR NON-INFECTIOUS DISEASES, 
BY COUNTRY, 2014–2021 (USD MILLION) 69
TABLE 40 BLOOD COLLECTION MARKET SIZE FOR TREATMENT APPLICATIONS, 
BY REGION, 2014–2021 (USD MILLION) 70
TABLE 41 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR TREATMENT APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 71
TABLE 42 EUROPE: BLOOD COLLECTION MARKET SIZE FOR TREATMENT APPLICATIONS, 
BY COUNTRY, 2014–2021 (USD MILLION) 71
TABLE 43 BLOOD COLLECTION MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 73
TABLE 44 BLOOD COLLECTION MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, 
BY REGION, 2014–2021 (USD MILLION) 75
TABLE 45 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2014–2021 (USD MILLION) 75
TABLE 46 EUROPE: BLOOD COLLECTION MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2014–2021 (USD MILLION) 75
TABLE 47 BLOOD COLLECTION MARKET SIZE FOR BLOOD BANKS, BY REGION, 
2014–2021 (USD MILLION) 77
TABLE 48 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR BLOOD BANKS, 
BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 49 EUROPE: BLOOD COLLECTION MARKET SIZE FOR BLOOD BANKS, BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 50 BLOOD COLLECTION MARKET SIZE FOR OTHER END USERS, BY REGION, 
2014–2021 (USD MILLION) 78
TABLE 51 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR OTHER END USERS, 
BY COUNTRY, 2014–2021 (USD MILLION) 79
TABLE 52 EUROPE: BLOOD COLLECTION MARKET SIZE FOR OTHER END USERS, 
BY COUNTRY, 2014–2021 (USD MILLION) 79
TABLE 53 BLOOD COLLECTION MARKET SIZE, BY REGION 2014–2021 (USD MILLION) 82
TABLE 54 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 
2014–2021 (USD MILLION) 85
TABLE 55 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 86
TABLE 56 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR BLOOD COLLECTION TUBES, BY TYPE, 2014–2021 (USD MILLION) 86
TABLE 57 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 87
TABLE 58 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, 
BY TYPE, 2014–2021 (USD MILLION) 87
TABLE 59 NORTH AMERICA: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 87
TABLE 60 U.S.: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 88
TABLE 61 U.S.: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 89
TABLE 62 U.S.: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, BY TYPE, 
2014–2021 (USD MILLION) 89
TABLE 63 U.S.: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 90
TABLE 64 CANADA: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 91
TABLE 65 CANADA: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 92
TABLE 66 CANADA: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, 
BY TYPE, 2014–2021 (USD MILLION) 92
TABLE 67 CANADA: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 92
TABLE 68 EUROPE: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 94
TABLE 69 EUROPE: BLOOD COLLECTION MARKET SIZE FOR BLOOD COLLECTION TUBES, 
BY TYPE, 2014–2021 (USD MILLION) 95
TABLE 70 EUROPE: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 95
TABLE 71 EUROPE: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, 
BY TYPE, 2014–2021 (USD MILLION) 95
TABLE 72 EUROPE: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 96
TABLE 73 GERMANY: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 96
TABLE 74 GERMANY: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 97
TABLE 75 GERMANY: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, 
BY TYPE, 2014–2021 (USD MILLION) 97
TABLE 76 GERMANY: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 98
TABLE 77 U.K.: BLOOD COLLECTION SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 98
TABLE 78 U.K.: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 99
TABLE 79 U.K.: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, BY TYPE, 
2014–2021 (USD MILLION) 99
TABLE 80 U.K.: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 100
TABLE 81 FRANCE: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 101
TABLE 82 FRANCE: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 101
TABLE 83 FRANCE: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, 
BY TYPE, 2014–2021 (USD MILLION) 102
TABLE 84 FRANCE: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 102
TABLE 85 ROE: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 103
TABLE 86 ROE: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 104
TABLE 87 ROE: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, 
BY TYPE, 2014–2021 (USD MILLION) 105
TABLE 88 ROE: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 105
TABLE 89 ASIA-PACIFIC: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 108
TABLE 90 ASIA-PACIFIC: BLOOD COLLECTION MARKET SIZE FOR BLOOD COLLECTION TUBES, BY TYPE, 2014–2021 (USD MILLION) 109
TABLE 91 ASIA-PACIFIC: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 109
TABLE 92 ASIA-PACIFIC: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, 
BY TYPE, 2014–2021 (USD MILLION) 110
TABLE 93 ASIA-PACIFIC: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 110
TABLE 94 ROW: BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 
2014–2021 (USD MILLION) 111
TABLE 95 ROW: BLOOD COLLECTION MARKET SIZE FOR BLOOD COLLECTION TUBES, 
BY TYPE, 2014–2021 (USD MILLION) 112
TABLE 96 ROW: BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2014–2021 (USD MILLION) 112
TABLE 97 ROW: BLOOD COLLECTION MARKET SIZE FOR DIAGNOSTICS, 
BY TYPE, 2014–2021 (USD MILLION) 112
TABLE 98 ROW: BLOOD COLLECTION MARKET SIZE, BY END USER, 
2014–2021 (USD MILLION) 113
TABLE 99 PRODUCT LAUNCHES, 2013–2016 117
TABLE 100 ACQUISITIONS, 2013–2016 118
TABLE 101 EXPANSIONS, 2013–2016 119
TABLE 102 AGREEMENTS AND PARTNERSHIPS, 2013–2016 120
TABLE 103 OTHER DEVELOPMENTS, 2013–2016 121
 
List Of Figures
FIGURE 1 RESEARCH DESIGN 18
FIGURE 2 MARKET SIZE ESTIMATION APPROACH 20
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 4 DATA TRIANGULATION METHODOLOGY 22
FIGURE 5 BLOOD COLLECTION MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION) 26
FIGURE 6 BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 
2016 VS. 2021 (USD MILLION) 27
FIGURE 7 BLOOD COLLECTION MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION) 27
FIGURE 8 GLOBAL BLOOD COLLECTION MARKET, BY REGION, 2015 (USD MILLION) 28
FIGURE 9 RISING PREVALENCE OF VARIOUS DISEASES AND GROWING NUMBER OF ACCIDENTAL & TRAUMA CASES—PROPELLING THE GROWTH OF THE BLOOD COLLECTION MARKET 30
FIGURE 10 BLOOD COLLECTION NEEDLES & SYRINGES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016 31
FIGURE 11 INFECTIOUS DISEASES SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 32
FIGURE 12 HOSPITALS & DIAGNOSTICS CENTERS ARE THE MAJOR END USERS OF THE BLOOD COLLECTION MARKET 32
FIGURE 13 DIAGNOSTICS SEGMENT TO ACCOUNT FOR THE MAJOR SHARE OF THE BLOOD COLLECTION MARKET IN 2016 33
FIGURE 14 ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 15 ASIA-PACIFIC SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 34
FIGURE 16 BLOOD COLLECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 37
FIGURE 17 BLOOD COLLECTION NEEDLES AND SYRINGES SEGMENT TO DOMINATE THE BLOOD COLLECTION PRODUCTS MARKET DURING THE FORECAST PERIOD 43
FIGURE 18 NORTH AMERICA TO DOMINATE THE BLOOD COLLECTION NEEDLES AND SYRINGES MARKET DURING THE FORECAST PERIOD 44
FIGURE 19 ASIA-PACIFIC TO SHOWCASE HIGHEST GROWTH RATE IN THE BLOOD COLLECTION TUBES MARKET DURING THE FORECAST PERIOD 46
FIGURE 20 EDTA COLLECTION TUBES TO DOMINATE THE BLOOD COLLECTION TUBES MARKET FROM 2016 TO 2021 48
FIGURE 21 NORTH AMERICA IS EXPECTED TO DOMINATE THE BLOOD LANCETS MARKET FROM 2016 TO 2021 53
FIGURE 22 ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN BLOOD BAGS MARKET DURING THE FORECAST PERIOD 55
FIGURE 23 NORTH AMERICA TO DOMINATE THE VIALS MARKET FROM 2016 TO 2021 57
FIGURE 24 ASIA-PACIFIC TO SHOWCASE HIGHEST GROWTH RATE FROM 2016 TO 2021 59
FIGURE 25 DIAGNOSTIC APPLICATIONS SEGMENT TO DOMINATE THE BLOOD COLLECTION MARKET DURING THE FORECAST PERIOD 62
FIGURE 26 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BLOOD COLLECTION MARKET FOR DIAGNOSTIC APPLICATIONS DURING THE FORECAST PERIOD 63
FIGURE 27 NORTH AMERICA TO DOMINATE THE BLOOD COLLECTION MARKET FOR INFECTIOUS DISEASES DURING THE FORECAST PERIOD 66
FIGURE 28 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH IN THE BLOOD COLLECTION MARKET FOR NON-INFECTIOUS DISEASES 68
FIGURE 29 NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD COLLECTION MARKET FOR TREATMENT APPLICATIONS 70
FIGURE 30 HOSPITALS AND DIAGNOSTIC CENTERS WILL CONTINUE TO DOMINATE THE BLOOD COLLECTION END-USER MARKET IN 2021 73
FIGURE 31 NORTH AMERICA TO DOMINATE THE BLOOD COLLECTION MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS 74
FIGURE 32 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BLOOD COLLECTION MARKET FOR BLOOD BANKS IN 2021 76
FIGURE 33 ASIA- PACIFIC TO WITNESS THE HIGHEST GROWTH FOR OTHER END USERS SEGMENT DURING THE FORECAST PERIOD 78
FIGURE 34 BLOOD COLLECTION MARKET: GEOGRAPHIC SNAPSHOT 81
FIGURE 35 ASIA-PACIFIC BLOOD COLLECTION MARKET SHOWS SIGNIFICANT GROWTH OPPORTUNITIES 82
FIGURE 36 NORTH AMERICA: BLOOD COLLECTION MARKET SNAPSHOT (2016) 84
FIGURE 37 BLOOD COLLECTION NEEDLES AND SYRINGES TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET, IN 2016 85
FIGURE 38 DIAGNOSTICS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. BLOOD COLLECTION MARKET, BY APPLICATION 89
FIGURE 39 HOSPITALS AND DIAGNOSTICS CENTERS END-USER SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 91
FIGURE 40 EUROPE: BLOOD COLLECTION MARKET SNAPSHOT (2016) 93
FIGURE 41 BLOOD COLLECTION NEEDLES AND SYRINGES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN BLOOD COLLECTION MARKET 94
FIGURE 42 DIAGNOSTICS APPLICATION SEGMENT TO WITNESS HIGHEST GROWTH IN THE GERMAN BLOOD COLLECTION MARKET 97
FIGURE 43 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT IN U.K. SHOWS LUCRATIVE GROWTH OPPORTUNITIES 100
FIGURE 44 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN THE FRENCH BLOOD COLLECTION MARKET 102
FIGURE 45 DIAGNOSTICS APPLICATION SEGMENT TO GROW AT THE HIGHEST RATE IN THE ROE BLOOD COLLECTION MARKET 104
FIGURE 46 ASIA-PACIFIC BLOOD COLLECTION MARKET SNAPSHOT (2016) 107
FIGURE 47 BLOOD COLLECTION NEEDLES AND SYRINGES SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC BLOOD COLLECTION MARKET 108
FIGURE 48 BLOOD COLLECTION NEEDLES AND SYRINGES SEGMENT TO WITNESS HIGHEST GROWTH IN THE ROW MARKET, BY PRODUCT 111
FIGURE 49 COMPANIES MAJORLY PURSUED THE STRATEGY OF PRODUCT LAUNCHES FROM 2013 TO JULY 2016 115
FIGURE 50 PRODUCT LAUNCHES -KEY GROWTH STRATEGY BY MARKET PLAYERS 116
FIGURE 51 GEOGRAPHIC REVENUE MIX OF TOP 5 PLAYERS 122
FIGURE 52 COMPANY SNAPSHOT: ABBOTT LABORATORIES INC. 123
FIGURE 53 COMPANY SNAPSHOT: MEDTRONIC 125
FIGURE 54 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY 128
FIGURE 55 COMPANY SNAPSHOT: TERUMO CORPORATION 131
FIGURE 56 COMPANY SNAPSHOT: NIPRO MEDICAL CORPORATION 133
FIGURE 57 COMPANY SNAPSHOT: QIAGEN 136
FIGURE 58 COMPANY SNAPSHOT: GREINER HOLDING AG 140
FIGURE 59 COMPANY SNAPSHOT: HAEMONETICS CORPORATION 143
 

关于我们|联系我们|常见问题|服务项目|购买流程
2005-2013 All rights reserved.京ICP备05069564号-4 京公网安备110108 02010359号
全国服务热线:400-009-0050北京:010-82863481上海:021-64871266

在线客服系统